-

Legislation Eliminates Financial Barriers to Critical Breast Imaging, Would Help Thousands Across Arizona Afford Care They Require

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage

PHOENIX--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization commends Senator Hildy Angius (R-Bullhead City) for introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening.

The exorbitant out-of-pocket costs associated with this critical breast imaging procedure, ranging from hundreds to thousands of dollars, often force individuals to make significant financial sacrifices or forego tests that can confirm or rule out cancer.

“Nobody should be forced to skip medical care that helps to detect breast cancer early because of the cost, yet thousands of Arizonans are forced to make that decision every year,” said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen. “This bill will remove the financial barrier so that individuals can get the medically necessary early detection services they need without having to endure undue financial burden. This is a pivotal step toward reducing the overall health care costs by enabling earlier detection of the disease and more timely treatment.”

Unfortunately, when a mammogram reveals an abnormality or an individual is at higher risk of breast cancer, diagnostic and supplemental imaging is required to complete their early detection process. SB 1165, introduced by Sen. Angius, eliminates the patient’s out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging such as breast MRIs and ultrasounds.

“30 states, ranging across the political spectrum, have acknowledged the importance of removing financial barriers to lifesaving diagnostic testing for breast cancer at a critical time in a woman’s life,” said Sen. Angius.

A Komen-commissioned study found out-of-pockets costs for patients to range from $234 for a diagnostic mammogram to more than $1,000 for a breast MRI. Another recent study published in Radiology found that 1 in 5 patients said they would not go in for recommended follow-up imaging if they had to pay a deductible. By eliminating burdensome financial barriers to comprehensive preventive care, we can drive earlier detection, improve outcomes, reduce the overall costs to the health care system and create a healthier more productive workforce.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Amy Jo Steinbruecker
Susan G. Komen
972-701-2071
asteinbruecker@komen.org

Susan G. Komen


Release Versions

Contacts

Amy Jo Steinbruecker
Susan G. Komen
972-701-2071
asteinbruecker@komen.org

More News From Susan G. Komen

Susan G. Komen® to Deliver Urgent Message at Second Annual October Party in Pink Event: “Ending Deaths from Breast Cancer is Within Our Grasp; Together We Will Make it Happen”

NEW YORK--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, is doubling down on its mission “to end deaths from breast cancer” and rallying supporters at its second annual Party in Pink in NYC on October 14th. The event is Komen’s largest opportunity for corporate leaders and philanthropists to commit critical support for people facing breast cancer today and in the future.This year alone, an estimated 321,910 women and 2,670 men in the U.S. will be diagnosed with...

Susan G. Komen® Applauds U.S. House Passage of Legislation That Will Make Breast Health Services More Accessible

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends members of the U.S. House of Representatives for passing H.R.4541, the EARLY Act Reauthorization of 2025. In addition to the important work of the EARLY Act, the bill included language from the SCREENS for Cancer Act to reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). The bill now awaits action by the U.S. Senate and Presidential signature before it can be...

Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today awarded $15.4 million in grants to cutting-edge breast cancer researchers who are bringing us closer to the cures for all breast cancers. The funded projects span some of the most promising areas of research, including the use of artificial intelligence for better health outcomes and vaccine-based approaches targeting the most aggressive and deadliest forms of breast cancer. In total, 35 researchers...
Back to Newsroom